Re: ZHCLF up 290% to $0.16...question
in response to
by
posted on
Dec 14, 2020 03:45PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
KOO - Still clears nothing up. We already knew that ZHCLF has been assigned to ZCC Calgary so no surprise that Calgary info. comes up for it. What we don't know is whether or not it has also been assigned to ZCC Vancouver. Both companies say they don't trade OTC so that tells nothing either.